{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["1,2,3-triazole", "A\u03b2 aggregation", "Biometal chelator", "BuChE inhibitor", "Chromenones", "Neuroprotectivity"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "33134975", "DateRevised": {"Year": "2020", "Month": "11", "Day": "03"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "10", "Day": "27"}], "Language": ["eng"], "ELocationID": ["64", "10.1186/s13065-020-00715-0"], "Journal": {"ISSN": "2661-801X", "JournalIssue": {"Volume": "14", "Issue": "1", "PubDate": {"Year": "2020", "Month": "Dec"}}, "Title": "BMC chemistry", "ISOAbbreviation": "BMC Chem"}, "ArticleTitle": "Design and synthesis of multi-target directed 1,2,3-triazole-dimethylaminoacryloyl-chromenone derivatives with potential use in Alzheimer's disease.", "Pagination": {"StartPage": "64", "MedlinePgn": "64"}, "Abstract": {"AbstractText": ["To discover multifunctional agents for the treatment of Alzheimer's disease (AD), a new series of 1,2,3-triazole-chromenone derivatives were designed and synthesized based on the multi target-directed ligands approach. The in vitro biological activities included acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibition as well as anti-A\u03b2 aggregation, neuroprotective effects, and metal-chelating properties. The results indicated a highly selective BuChE inhibitory activity with an IC<sub>50</sub> value of 21.71\u00a0\u03bcM for compound <b>10h</b> as the most potent compound. Besides, compound <b>10h</b> could inhibit self-induced A\u03b2<sub>1-42</sub> aggregation and AChE-induced A\u03b2 aggregation with 32.6% and 29.4% inhibition values, respectively. The\u00a0Lineweaver-Burk plot and molecular modeling study showed that compound <b>10h</b> targeted both the catalytic active site (CAS) and peripheral anionic site (PAS) of BuChE. It should be noted that compound <b>10h</b> was able to chelate biometals. Thus, the designed scaffold could be considered as multifunctional agents in\u00a0AD drug discovery developments."], "CopyrightInformation": "\u00a9 The Author(s) 2020."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": ["grid.411705.6", "0000 0001 0166 0922"], "Affiliation": "Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Karimi Askarani", "ForeName": "Hajar", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["grid.412571.4", "0000 0000 8819 4698"], "Affiliation": "Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, Iran."}], "LastName": "Iraji", "ForeName": "Aida", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["grid.411705.6", "0000 0001 0166 0922"], "Affiliation": "Persian Medicine and Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Rastegari", "ForeName": "Arezoo", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["grid.440748.b", "0000 0004 1756 6705"], "Affiliation": "Department of Pharmaceutical Chemistry, College of Pharmacy, Aljouf University, Sakaka, 2014 Aljouf Saudi Arabia."}], "LastName": "Abbas Bukhari", "ForeName": "Syed Nasir", "Initials": "SN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["grid.412571.4", "0000 0000 8819 4698"], "Affiliation": "Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, Iran."}], "LastName": "Firuzi", "ForeName": "Omidreza", "Initials": "O"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["grid.411705.6", "0000 0001 0166 0922"], "Affiliation": "Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}, {"Identifier": ["grid.411705.6", "0000 0001 0166 0922"], "Affiliation": "Persian Medicine and Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Akbarzadeh", "ForeName": "Tahmineh", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["grid.411705.6", "0000 0001 0166 0922"], "Affiliation": "Persian Medicine and Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, Iran."}, {"Identifier": ["grid.411705.6", "0000 0001 0166 0922"], "Affiliation": "Medicinal Plants Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Saeedi", "ForeName": "Mina", "Initials": "M"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "BMC Chem", "NlmUniqueID": "101741142", "ISSNLinking": "2661-801X"}, "CoiStatement": "Competing interestsThe authors declare that they have no competing interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Maramai S, Benchekroun M, Gabr MT, Yahiaoui S. Multitarget therapeutic strategies for Alzheimer\u2019s disease: Review on emerging target combinations. BioMed Res Int. 2020;2020:5120230. doi: 10.1155/2020/5120230.", "ArticleIdList": ["10.1155/2020/5120230", "PMC7354643", "32714977"]}, {"Citation": "Iraji A, Khoshneviszadeh M, Firuzi O, Khoshneviszadeh M, Edraki N. Novel small molecule therapeutic agents for Alzheimer disease: focusing on BACE1 and multi-target directed ligands. Bioorg Chem. 2020;97:103649. doi: 10.1016/j.bioorg.2020.103649.", "ArticleIdList": ["10.1016/j.bioorg.2020.103649", "32101780"]}, {"Citation": "Najafi Z, Mahdavi M, Saeedi M, Karimpour-Razkenari E, Asatouri R, Vafadarnejad F, Moghadam FH, Khanavi M, Sharifzadeh M, Akbarzadeh T. Novel tacrine-1,2,3-triazole hybrids: in vitro, in vivo biological evaluation and docking study of cholinesterase inhibitors. Eur J Med Chem. 2017;125:1200\u20131212. doi: 10.1016/j.ejmech.2016.11.008.", "ArticleIdList": ["10.1016/j.ejmech.2016.11.008", "27863370"]}, {"Citation": "Rahman A. Frontiers in clinical drug research-CNS and neurological disorders. Sharjah: Bentham Science Publishers; 2018."}, {"Citation": "Li Q, Yang H, Chen Y, Sun H. Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease. Eur J Med Chem. 2017;132:294\u2013309. doi: 10.1016/j.ejmech.2017.03.062.", "ArticleIdList": ["10.1016/j.ejmech.2017.03.062", "28371641"]}, {"Citation": "Vafadarnejad F, Karimpour-Razkenari E, Sameem B, Saeedi M, Firuzi O, Edraki N, Mahdavi M, Akbarzadeh T. Novel N-benzylpyridinium moiety linked to arylisoxazole derivatives as selective butyrylcholinesterase inhibitors: synthesis, biological evaluation, and docking study. Bioorg Chem. 2019;92:103192. doi: 10.1016/j.bioorg.2019.103192.", "ArticleIdList": ["10.1016/j.bioorg.2019.103192", "31446239"]}, {"Citation": "Campanari M-L, Navarrete F, Ginsberg SD, Manzanares J, S\u00e1ez-Valero J. Garc\u00eda-Ayll\u00f3n M-S (2016) Increased expression of readthrough acetylcholinesterase variants in the brains of Alzheimer\u2019s disease patients. J Alzheimers Dis. 2016;53(3):831\u2013841. doi: 10.3233/JAD-160220.", "ArticleIdList": ["10.3233/JAD-160220", "PMC5013723", "27258420"]}, {"Citation": "Darvesh S, Hopkins DA, Geula C. Neurobiology of butyrylcholinesterase. Nat Rev Neurosci. 2003;4(2):131. doi: 10.1038/nrn1035.", "ArticleIdList": ["10.1038/nrn1035", "12563284"]}, {"Citation": "Maurice T, Strehaiano M, Sim\u00e9on N, Bertrand C, Chatonnet A. Learning performances and vulnerability to amyloid toxicity in the butyrylcholinesterase knockout mouse. Behav Brain Res. 2016;296:351\u2013360. doi: 10.1016/j.bbr.2015.08.026.", "ArticleIdList": ["10.1016/j.bbr.2015.08.026", "26306824"]}, {"Citation": "Dolles D, Hoffmann M, Gunesch S, Marinelli O, M\u00f6ller J, Santoni G, Chatonnet A, Lohse MJ, Wittmann H-J, Strasser A. Structure\u2013activity relationships and computational investigations into the development of potent and balanced dual-acting butyrylcholinesterase inhibitors and human cannabinoid receptor 2 ligands with pro-cognitive in vivo profiles. J Med Chem. 2018;61(4):1646\u20131663. doi: 10.1021/acs.jmedchem.7b01760.", "ArticleIdList": ["10.1021/acs.jmedchem.7b01760", "29400965"]}, {"Citation": "Greig NH, Utsuki T, Ingram DK, Wang Y, Pepeu G, Scali C, Yu Q-S, Mamczarz J, Holloway HW, Giordano T. Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer \u03b2-amyloid peptide in rodent. Proc Natl Acad Sci. 2005;102(47):17213\u201317218. doi: 10.1073/pnas.0508575102.", "ArticleIdList": ["10.1073/pnas.0508575102", "PMC1288010", "16275899"]}, {"Citation": "Soreq H: Human cholinesterases and anticholinesterases: Academic Press; 2012."}, {"Citation": "Lane RM, Potkin SG, Enz A. Targeting acetylcholinesterase and butyrylcholinesterase in dementia. Int J Neuropsychopharmacol. 2006;9(1):101\u2013124. doi: 10.1017/S1461145705005833.", "ArticleIdList": ["10.1017/S1461145705005833", "16083515"]}, {"Citation": "Nicolet Y, Lockridge O, Masson P, Fontecilla-Camps JC, Nachon F. Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products. J Biol Chem. 2003;278(42):41141\u201341147. doi: 10.1074/jbc.M210241200.", "ArticleIdList": ["10.1074/jbc.M210241200", "12869558"]}, {"Citation": "Tripathi MK, Sharma P, Tripathi A, Tripathi PN, Srivastava P, Seth A, Shrivastava SK. Computational exploration and experimental validation to identify a dual inhibitor of cholinesterase and amyloid-beta for the treatment of Alzheimer\u2019s disease. J Comput Aided Mol Des. 2020;34(9):983\u20131002. doi: 10.1007/s10822-020-00318-w.", "ArticleIdList": ["10.1007/s10822-020-00318-w", "32488355"]}, {"Citation": "Sharma P, Srivastava P, Seth A, Tripathi PN, Banerjee AG, Shrivastava SK. Comprehensive review of mechanisms of pathogenesis involved in Alzheimer\u2019s disease and potential therapeutic strategies. Prog Neurobiol. 2019;174:53\u201389. doi: 10.1016/j.pneurobio.2018.12.006.", "ArticleIdList": ["10.1016/j.pneurobio.2018.12.006", "30599179"]}, {"Citation": "Cherny RA, Atwood CS, Xilinas ME, Gray DN, Jones WD, McLean CA, Barnham KJ, Volitakis I, Fraser FW, Kim Y-S. Treatment with a copper-zinc chelator markedly and rapidly inhibits \u03b2-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron. 2001;30(3):665\u2013676. doi: 10.1016/S0896-6273(01)00317-8.", "ArticleIdList": ["10.1016/S0896-6273(01)00317-8", "11430801"]}, {"Citation": "Zatta P, Drago D, Bolognin S, Sensi SL. Alzheimer's disease, metal ions and metal homeostatic therapy. Trends Pharmacol Sci. 2009;30(7):346\u2013355. doi: 10.1016/j.tips.2009.05.002.", "ArticleIdList": ["10.1016/j.tips.2009.05.002", "19540003"]}, {"Citation": "Andrisano V, Naldi M, De Simone A, Bartolini M. A patent review of butyrylcholinesterase inhibitors and reactivators 2010\u20132017. Expert Opin Ther Pat. 2018;28(6):455\u2013465. doi: 10.1080/13543776.2018.1476494.", "ArticleIdList": ["10.1080/13543776.2018.1476494", "29757691"]}, {"Citation": "Vafadarnejad F, Mahdavi M, Karimpour-Razkenari E, Edraki N, Sameem B, Khanavi M, Saeedi M, Akbarzadeh T. Design and synthesis of novel coumarin-pyridinium hybrids: In vitro cholinesterase inhibitory activity. Bioorg Chem. 2018;77:311\u2013319. doi: 10.1016/j.bioorg.2018.01.013.", "ArticleIdList": ["10.1016/j.bioorg.2018.01.013", "29421707"]}, {"Citation": "Saeedi M, Safavi M, Karimpour-Razkenari E, Mahdavi M, Edraki N, Moghadam FH, Khanavi M, Akbarzadeh T. Synthesis of novel chromenones linked to 1,2,3-triazole ring system: investigation of biological activities against Alzheimer\u2019s disease. Bioorg Chem. 2017;70:86\u201393. doi: 10.1016/j.bioorg.2016.11.011.", "ArticleIdList": ["10.1016/j.bioorg.2016.11.011", "27914694"]}, {"Citation": "Yazdani M, Edraki N, Badri R, Khoshneviszadeh M, Iraji A, Firuzi O. 5,6-Diphenyl triazine-thio methyl triazole hybrid as a new Alzheimer\u2019s disease modifying agents. Mol Divers. 2020;24:641\u2013654. doi: 10.1007/s11030-019-09970-3.", "ArticleIdList": ["10.1007/s11030-019-09970-3", "31327094"]}, {"Citation": "Moradi A, Faraji L, Nadri H, Hasanpour Z, Moghadam FH, Pakseresht B, Golshani M, Moghimi S, Ramazani A, Firoozpour L, et al. Synthesis, docking study, and biological evaluation of novel umbellipherone/hymecromone derivatives as acetylcholinesterase/butyrylcholinesterase inhibitors. Med Chem Res. 2018;27(7):1741\u20131747. doi: 10.1007/s00044-018-2187-8.", "ArticleIdList": ["10.1007/s00044-018-2187-8"]}, {"Citation": "Fang J, Li Y, Liu R, Pang X, Li C, Yang R, He Y, Lian W, Liu A-L, Du G-H. Discovery of multitarget-directed ligands against Alzheimer\u2019s disease through systematic prediction of chemical\u2013protein interactions. J Chem Inf Model. 2015;55(1):149\u2013164. doi: 10.1021/ci500574n.", "ArticleIdList": ["10.1021/ci500574n", "25531792"]}, {"Citation": "Jiang Z, You Q, Zhang X. Medicinal chemistry of metal chelating fragments in metalloenzyme active sites: a perspective. Eur J Med Chem. 2019;165:172\u2013197. doi: 10.1016/j.ejmech.2019.01.018.", "ArticleIdList": ["10.1016/j.ejmech.2019.01.018", "30684796"]}, {"Citation": "Kostova I, Bhatia S, Grigorov P, Balkansky S, Parmar VS, Prasad AK, Saso L. Coumarins as antioxidants. Curr Med Chem. 2011;18(25):3929\u20133951. doi: 10.2174/092986711803414395.", "ArticleIdList": ["10.2174/092986711803414395", "21824098"]}, {"Citation": "Tao D, Wang Y, Bao X-Q, Yang B-B, Gao F, Wang L, Zhang D, Li L. Discovery of coumarin Mannich base derivatives as multifunctional agents against monoamine oxidase B and neuroinflammation for the treatment of Parkinson's disease. Eur J Med Chem. 2019;173:203\u2013212. doi: 10.1016/j.ejmech.2019.04.016.", "ArticleIdList": ["10.1016/j.ejmech.2019.04.016", "31005056"]}, {"Citation": "Najafi Z, Mahdavi M, Saeedi M, Karimpour-Razkenari E, Edraki N, Sharifzadeh M, Khanavi M, Akbarzadeh T. Novel tacrine-coumarin hybrids linked to 1,2,3-triazole as anti-Alzheimer\u2019s compounds: In vitro and in vivo biological evaluation and docking study. Bioorg Chem. 2019;83:303\u2013316. doi: 10.1016/j.bioorg.2018.10.056.", "ArticleIdList": ["10.1016/j.bioorg.2018.10.056", "30396115"]}, {"Citation": "Jalili-Baleh L, Nadri H, Forootanfar H, Samzadeh-Kermani A, K\u00fc\u00e7\u00fckk\u0131l\u0131n\u00e7 TT, Ayazgok B, Rahimifard M, Baeeri M, Doostmohammadi M, Firoozpour L, et al. Novel 3-phenylcoumarin-lipoic acid conjugates as multi-functional agents for potential treatment of Alzheimer's disease. Bioorg Chem. 2018;79:223\u2013234. doi: 10.1016/j.bioorg.2018.04.030.", "ArticleIdList": ["10.1016/j.bioorg.2018.04.030", "29775948"]}, {"Citation": "Jiang N, Huang Q, Liu J, Liang N, Li Q, Li Q, Xie S-S. Design, synthesis and biological evaluation of new coumarin-dithiocarbamate hybrids as multifunctional agents for the treatment of Alzheimer's disease. Eur J Med Chem. 2018;146:287\u2013298. doi: 10.1016/j.ejmech.2018.01.055.", "ArticleIdList": ["10.1016/j.ejmech.2018.01.055", "29407958"]}, {"Citation": "Jalili-Baleh L, Forootanfar H, K\u00fc\u00e7\u00fckk\u0131l\u0131n\u00e7 TT, Nadri H, Abdolahi Z, Ameri A, Jafari M, Ayazgok B, Baeeri M, Rahimifard M, et al. Design, synthesis and evaluation of novel multi-target-directed ligands for treatment of Alzheimer's disease based on coumarin and lipoic acid scaffolds. Eur J Med Chem. 2018;152:600\u2013614. doi: 10.1016/j.ejmech.2018.04.058.", "ArticleIdList": ["10.1016/j.ejmech.2018.04.058", "29763808"]}, {"Citation": "Sang Z, Wang K, Shi J, Liu W, Cheng X, Zhu G, Wang Y, Zhao Y, Qiao Z, Wu A, et al. The development of advanced structural framework as multi-target-directed ligands for the treatment of Alzheimer\u2019s disease. Eur J Med Chem. 2020;192:112180. doi: 10.1016/j.ejmech.2020.112180.", "ArticleIdList": ["10.1016/j.ejmech.2020.112180", "32131034"]}, {"Citation": "Iraji A, Firuzi O, Khoshneviszadeh M, Tavakkoli M, Mahdavi M, Nadri H, Edraki N, Miri R. Multifunctional iminochromene-2H-carboxamide derivatives containing different aminomethylene triazole with BACE1 inhibitory, neuroprotective and metal chelating properties targeting Alzheimer's disease. Eur J Med Chem. 2017;141:690\u2013702. doi: 10.1016/j.ejmech.2017.09.057.", "ArticleIdList": ["10.1016/j.ejmech.2017.09.057", "29107423"]}, {"Citation": "Jiang Y, Liu G, Wang X, Hu J, Zhang G, Liu S. Cytosol-specific fluorogenic reactions for visualizing intracellular disintegration of responsive polymeric nanocarriers and triggered drug release. Macromolecules. 2015;48(3):764\u2013774. doi: 10.1021/ma502389w.", "ArticleIdList": ["10.1021/ma502389w"]}, {"Citation": "Lewis WG, Green LG, Grynszpan F, Radi\u0107 Z, Carlier PR, Taylor P, Finn M, Sharpless KB. Click chemistry in situ: acetylcholinesterase as a reaction vessel for the selective assembly of a femtomolar inhibitor from an array of building blocks. Angew Chem Int Ed. 2002;41(6):1053\u20131057. doi: 10.1002/1521-3773(20020315)41:6<1053::AID-ANIE1053>3.0.CO;2-4.", "ArticleIdList": ["10.1002/1521-3773(20020315)41:6<1053::AID-ANIE1053>3.0.CO;2-4", "12491310"]}, {"Citation": "Ellman GL, Courtney KD, Andres V, Jr, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961;7(2):88\u201395. doi: 10.1016/0006-2952(61)90145-9.", "ArticleIdList": ["10.1016/0006-2952(61)90145-9", "13726518"]}, {"Citation": "Rold\u00e1n-Pe\u00f1a JM, Romero-Real V, Hicke J, Maya I, Franconetti A, Lagunes I, Padr\u00f3n JM, Petralla S, Poeta E, Naldi M, et al. Tacrine-O-protected phenolics heterodimers as multitarget-directed ligands against Alzheimer's disease: Selective subnanomolar BuChE inhibitors. Eur J Med chem. 2019;181:111550. doi: 10.1016/j.ejmech.2019.07.053.", "ArticleIdList": ["10.1016/j.ejmech.2019.07.053", "31376562"]}, {"Citation": "Drew SC. The case for abandoning therapeutic chelation of copper ions in Alzheimer's Disease. Front Neurosci. 2017;11:317. doi: 10.3389/fnins.2017.00317.", "ArticleIdList": ["10.3389/fnins.2017.00317", "PMC5455140", "28626387"]}, {"Citation": "Nachon F, Carletti E, Ronco C, Trovaslet M, Nicolet Y, Jean L, Renard P-Y. Crystal structures of human cholinesterases in complex with huprine W and tacrine: elements of specificity for anti-Alzheimer's drugs targeting acetyl-and butyryl-cholinesterase. Biochem J. 2013;453(3):393\u2013399. doi: 10.1042/BJ20130013.", "ArticleIdList": ["10.1042/BJ20130013", "23679855"]}, {"Citation": "Chandrasekaran B, Abed SN, Al-Attraqchi O, Kuche K, Tekade RK. Chapter 21\u2014Computer-Aided Prediction of Pharmacokinetic (ADMET) Properties. In: Dosage Form Design Parameters. edn. Edited by Tekade RK: Academic Press; 2018. p. 731\u2013755."}, {"Citation": "Liu G, Shi G, Sheng H, Jiang Y, Liang H, Liu S. Doubly caged linker for and-type fluorogenic construction of protein/antibody bioconjugates and in situ quantification. Angew Chem. 2017;129(30):8812\u20138817. doi: 10.1002/ange.201702748.", "ArticleIdList": ["10.1002/ange.201702748", "28524357"]}, {"Citation": "Rastegari A, Nadri H, Mahdavi M, Moradi A, Mirfazli SS, Edraki N, Moghadam FH, Larijani B, Akbarzadeh T, Saeedi M. Design, synthesis and anti-Alzheimer\u2019s activity of novel 1, 2, 3-triazole-chromenone carboxamide derivatives. Bioorg Chem. 2019;83:391\u2013401. doi: 10.1016/j.bioorg.2018.10.065.", "ArticleIdList": ["10.1016/j.bioorg.2018.10.065", "30412794"]}, {"Citation": "Saeedi M, Mohtadi-Haghighi D, Mirfazli SS, Mahdavi M, Hariri R, Lotfian H, Edraki N, Iraji A, Firuzi O, Akbarzadeh T. Design and synthesis of selective acetylcholinesterase inhibitors: arylisoxazole-phenylpiperazine derivatives. Chem Biodivers. 2019;16(2):e1800433. doi: 10.1002/cbdv.201800433.", "ArticleIdList": ["10.1002/cbdv.201800433", "30460743"]}, {"Citation": "Mahdavi M, Hariri R, Mirfazli SS, Lotfian H, Rastergari A, Firuzi O, Edraki N, Larijani B, Akbarzadeh T, Saeedi M. Synthesis and biological activity of some benzochromenoquinolinones: tacrine analogs as potent anti-Alzheimer's agents. Chem Biodivers. 2019;16(4):e1800488. doi: 10.1002/cbdv.201800488.", "ArticleIdList": ["10.1002/cbdv.201800488", "30720917"]}, {"Citation": "Jalili-Baleh L, Nadri H, Moradi A, Bukhari SNA, Shakibaie M, Jafari M, Golshani M, Homayouni Moghadam F, Firoozpour L, Asadipour A, et al. New racemic annulated pyrazolo[1,2-b]phthalazines as tacrine-like AChE inhibitors with potential use in Alzheimer's disease. Eur J Med Chem. 2017;139:280\u2013289. doi: 10.1016/j.ejmech.2017.07.072.", "ArticleIdList": ["10.1016/j.ejmech.2017.07.072", "28803044"]}, {"Citation": "Yazdani M, Edraki N, Badri R, Khoshneviszadeh M, Iraji A, Firuzi O. Multi-target inhibitors against Alzheimer disease derived from 3-hydrazinyl 1,2,4-triazine scaffold containing pendant phenoxy methyl-1,2,3-triazole: design, synthesis and biological evaluation. Bioorg Chem. 2019;84:363\u2013371. doi: 10.1016/j.bioorg.2018.11.038.", "ArticleIdList": ["10.1016/j.bioorg.2018.11.038", "30530107"]}, {"Citation": "Iraji A, Firuzi O, Khoshneviszadeh M, Nadri H, Edraki N, Miri R. Synthesis and structure-activity relationship study of multi-target triazine derivatives as innovative candidates for treatment of Alzheimer's disease. Bioorg Chem. 2018;77:223\u2013235. doi: 10.1016/j.bioorg.2018.01.017.", "ArticleIdList": ["10.1016/j.bioorg.2018.01.017", "29367079"]}, {"Citation": "Karama\u0107 M. Chelation of Cu (II), Zn (II), and Fe (II) by tannin constituents of selected edible nuts. Int J Mol Sci. 2009;10(12):5485\u20135497. doi: 10.3390/ijms10125485.", "ArticleIdList": ["10.3390/ijms10125485", "PMC2802006", "20054482"]}, {"Citation": "Iraji A, Adelpour T, Edraki N, Khoshneviszadeh M, Miri R, Khoshneviszadeh M. Synthesis, biological evaluation and molecular docking analysis of vaniline-benzylidenehydrazine hybrids as potent tyrosinase inhibitors. BMC Chem. 2020;14(1):28. doi: 10.1186/s13065-020-00679-1.", "ArticleIdList": ["10.1186/s13065-020-00679-1", "PMC7137441", "32280949"]}]}], "History": [{"Year": "2020", "Month": "7", "Day": "8"}, {"Year": "2020", "Month": "10", "Day": "8"}, {"Year": "2020", "Month": "11", "Day": "2", "Hour": "6", "Minute": "23"}, {"Year": "2020", "Month": "11", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "11", "Day": "3", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "10", "Day": "27"}], "PublicationStatus": "epublish", "ArticleIdList": ["33134975", "PMC7592376", "10.1186/s13065-020-00715-0", "715"]}}]}